Which company manufactures Mounjaro?

Mounjaro, the brand name for tirzepatide, is manufactured by Eli Lilly and Company, a global pharmaceutical corporation. This medication is a once-weekly injectable prescription drug approved by the U.S. Food and Drug Administration (FDA) in May 2022 for the treatment of type 2 diabetes. Mounjaro works as a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, helping to lower blood sugar levels and supporting weight management when used in conjunction with diet and exercise. Eli Lilly and Company, known for its commitment to diabetes care, has been spearheading innovations in diabetes treatments for many years.